Dynamic changes in WIfI classification as a prognostic indicator for midterm outcomes in CLTI patients undergoing infrapopliteal endovascular revascularization Authors: Sensen Wu, Julong Guo, Zelin Guo, Jia Zheng, Henan Zheng, Fan Zhang, Xixiang Gao, Yongquan Gu, Lianrui Guo Published: 2025 ABSTRACT ObjectiveThis study aimed to evaluate the prognostic significance of early postoperative the Wound, Ischemia, and foot Infection (WIfI) stage changes in Chronic limb-threatening ischemia (CLTI) patients with infrapopliteal lesions undergoing endovascular revascularization.MethodsA total of 153 patients with infrapopliteal occlusive CLTI who underwent endovascular revascularization were prospectively enrolled. WIfI staging was performed preoperatively and reassessed within 1–3 days after the operation. Patients were categorized into two groups based on postoperative WIfI stage changes: the "WIfI-Improved Group" (postoperative WIfI stage improved by at least one level) and the "WIfI-Non-Improved Group" (no change or worsening in postoperative WIfI stage). Clinical outcomes, including major adverse events (MAEs), amputation-free survival (AFS), mortality, and major adverse limb events (MALEs), were assessed at 1 year postoperatively.ResultsThere were no statistically significant differences between the two groups in terms of demographic data and underlying comorbidities. Patients in the WIfI-Improved Group exhibited significantly lower risks of MAEs (Log-rank, P = 0.011), improved AFS (P = 0.011), and reduced mortality (P = 0.005) compared to the WIfI-Non-Improved Group. However, no statistically significant differences in MALEs were observed between the two groups (P = 0.209).ConclusionsPostoperative improvement in WIfI classification is a strong predictor of better 1-year outcomes, including reduced MAEs, improved AFS, and lower mortality, in CLTI patients undergoing infrapopliteal endovascular revascularization. Dynamic WIfI assessment can serve as a valuable tool for postoperative prognosis evaluation, risk stratification, and guiding individualized management strategies. Introduction Chronic limb-threatening ischemia (CLTI) represents the end stage of peripheral artery disease (PAD) and is associated with a markedly high risk of morbidity and mortality, with a major amputation rate of up to 25% within one year. With the rising prevalence of diabetes and atherosclerotic occlusive disease, the incidence of CLTI is also steadily increasing [1–5]. To better assess limb prognosis in patients with CLTI, the Society for Vascular Surgery (SVS) introduced the Wound, Ischemia, and foot Infection (WIfI) classification system in 2014 [6]. This system provides a comprehensive assessment based on three components: wound characteristics, severity of ischemia, and the presence of foot infection. It has been widely adopted for preoperative risk stratification and treatment planning. Numerous studies have demonstrated that higher preoperative WIfI stages are associated with increased risk of amputation, prolonged wound healing, and poorer amputation-free survival (AFS) [7–10]. In recent years, the WIfI classification has been incorporated into multiple international clinical practice guidelines [3, 11, 12]. However, as a static assessment tool, the WIfI classification may not fully capture the dynamic changes in a patient's condition following revascularization, particularly the impact of restored perfusion on long-term outcomes. In recent years, researchers have proposed using WIfI as a dynamic scoring system, with restaging performed after vascular reconstruction or podiatric interventions, which may enhance its predictive accuracy. Leithead and colleagues demonstrated that reclassifying the ischemia component of the WIfI score after vascular intervention was associated with improved AFS [13]. In a large-scale study of over 1,400 patients with CLTI at WIfI stages 3–4, Cheun et al. found that changes in WIfI stage within 7–14 days postoperatively were significantly associated with both 1-year and 5-year AFS and major adverse limb events (MALE). Notably, patients whose WIfI stage worsened postoperatively had a dismal 5-year AFS of only 19% [14]. Although previous studies have preliminarily demonstrated the value of WIfI restaging in postoperative risk assessment, its prognostic significance in specific treatment subgroups—particularly in patients with infrapopliteal lesions treated with endovascular revascularization—remains unclear. Infrapopliteal arterial disease is highly prevalent among patients with CLTI, especially those with diabetes or end-stage renal disease (ESRD). These lesions present unique pathological features and clinical challenges due to the interplay of multiple pathophysiological mechanisms, including atherosclerosis, vascular calcification, microcirculatory dysfunction, and metabolic disturbances. Such patients often exhibit diffuse distal arterial involvement, poor plantar arterial runoff, and severe medial calcification, all of which significantly limit the feasibility and efficacy of revascularization [15–18]. Therefore, it is necessary to independently evaluate the predictive utility of WIfI stage changes in this specific population. This study aims to focus on patients with infrapopliteal CLTI undergoing endovascular revascularization and to assess the prognostic value of early postoperative WIfI restaging in predicting key clinical outcomes—such as amputation rates, MALE, AFS, and wound healing. The ultimate goal is to provide evidence-based guidance for postoperative surveillance and personalized reintervention strategies. Materials and methods Patients and data collection From December 2021 to June 2023, we prospectively enrolled patients diagnosed with CLTI who underwent endovascular revascularization for infrapopliteal arterial disease at our vascular surgery department. Detailed inpatient data were collected, including demographic information (age, sex, height, weight), comorbidities (e.g., hypertension, diabetes, coronary artery disease, renal insufficiency), and comprehensive procedural details (lesion location, characteristics, and interventional techniques). All patients underwent regular postoperative follow-up. WIfI stage was performed for all patients before and after the operation. Generally, it was conducted within 3 days before the operation, and after the operation, it was usually carried out before the patient was discharged (typically within 1–3 days after the operation). The WIfI stage was determined according to the recommendations of the SVS [3]. The ischemia score was determined based on at least one of the following parameters: ankle-brachial index (ABI), ankle systolic pressure (ASP), toe pressure (TP), or transcutaneous partial pressure of oxygen (TcPO2); the wound score was graded according to the recommended standards of the SVS based on the wound area, depth, and exposure; the infection score was determined based on clinical manifestations, imaging, and laboratory-supported infection criteria. WIfI staging was independently performed by two experienced vascular surgeons, and if there was a disagreement, a third expert would make the final decision. The runoff score is based on the scoring method recommended by SVS [19]. It assesses the patency of the distal popliteal artery and the three main arteries (anterior tibial, posterior tibial, and peroneal arteries) by scoring their stenosis. 0 points: Vascular stenosis < 20%; 1 point: Vascular stenosis is 20%—49%; 2 points: Vascular stenosis 50%—99%; 2.5 points: The length of complete obstruction is < 1/2 of the total length; 3 points: Complete obstruction can reach the entire length. The popliteal artery score needs to be weighted and calculated. The total score for other below-the-knee outflow tracts is 3 points. The final score is the sum of the scores of the four vessels, with a total of 19 points. The score is based on the range and degree of arterial stenosis or occlusion, and the higher the value, the more severe the involvement of the outflow tract. Use the Chinese-ized Vascular Quality of Life scale (VascuQol) to assess the quality of life of the patients. Inclusion criteria were as follows: (1) Rutherford classification ≥ grade 4; (2) Presence of at least one infrapopliteal arterial lesion with ≥ 70% stenosis, with or without proximal inflow disease; (3) At least one infrapopliteal lesion treated with endovascular intervention, including the distal popliteal artery (P3 segment), anterior tibial artery, tibioperoneal trunk, posterior tibial artery, or peroneal artery; 4)A minimum follow-up duration of 12 months postoperatively. Exclusion criteria included: (1) Patients with non-occlusive arterial pathologies requiring intervention in the target vessel, such as aneurysm, dissection, or perforation; (2) Patients presenting with intermittent claudication or asymptomatic PAD; (3) Patients with acute limb ischemia or thromboangiitis obliterans; (4) Patients who had previously undergone major amputation on the target limb; (5) Patients with incomplete WIfI component data or important variables. Technical procedures Perioperative treatment plans and execution of endovascular procedures for enrolled patients were conducted by experienced physicians. Patients typically received antiplatelet therapy comprising aspirin 100 mg/day and clopidogrel 75 mg/day for a minimum of 3 days preoperatively, in addition to other medications for hypertension, diabetes, and dyslipidemia based on their medical history. Patients were positioned supine, and under either local or general anesthesia, a modified Seldinger technique was employed for percutaneous puncture access. Systemic anticoagulation with heparin 80 IU/kg was administered via sheath insertion, with additional heparin dosing adjusted as required during the procedure. Treatment strategies, including the decision to address inflow or outflow lesions, selection of infrapopliteal target vessels, specific post-lesion treatment modalities (e.g., drug-coated balloon usage, atherectomy, primary or bailout stenting, special balloons, etc.), and device dimensions, were determined by the operator based on lower limb angiography. Final angiography was performed prior to procedure completion to assess vascular patency and distal blood flow. Postoperatively, patients typically continued antiplatelet therapy with aspirin 100 mg once daily and clopidogrel 75 mg once daily for 3–6 months, followed by long-term monotherapy with a single antiplatelet agent. Lipid-lowering medications were prescribed based on lipid profiles, with low-density lipoprotein levels maintained below 1.8 mmol/L. Patients necessitating anticoagulation therapy due to concurrent lower limb arterial thrombosis or other conditions had perioperative and postoperative medication adjusted according to individual circumstances, with consideration given to escalating anticoagulants and adjusting antiplatelet agents as warranted. Health education was imparted to patients during hospitalization, with smoking cessation counseling offered to smokers. Patients with foot tissue defects were discharged for standardized wound repair treatment in outpatient or inpatient wound repair departments. Outcome measures and definition criteria The primary composite endpoint of this study was the incidence of major adverse events (MAEs), defined as the occurrence of any of the following: major amputation, all-cause mortality, or clinically driven target limb reintervention (CD-TLR); Major amputation was defined as any amputation above the ankle on the target limb; Amputation-free survival (AFS) was defined as survival without above-ankle amputation of the target limb and without death from any cause; CD-TLR was defined as any repeat revascularization procedure performed on the ipsilateral infrapopliteal artery due to recurrent clinical symptoms, major adverse limb events (MALE) include major amputations and CD-TLR in this study [20]. Patients were categorized into two groups based on the change in WIfI stage from preoperative to postoperative assessment: WIfI-Improved Group: a reduction of at least one stage in the postoperative WIfI classification compared to baseline; WIfI-Non-Improved Group: no change or any increase in WIfI stage postoperatively. Postoperative follow-up was scheduled at 3, 6, and 12 months after the index procedure, with day 0 defined as the date of surgery. Follow-up assessments were conducted through a combination of in-person outpatient visits and remote online consultations. Statistical methods Statistical analyses were executed using SPSS version 26.0 (IBM, Armonk, New York) and R version 4.2.2 (The R Foundation for Statistical Computing, Vienna, Austria). The analysis included measures such as mean (standard deviation) for normally distributed variables and median (IQR) for non-normally distributed variables for continuous variables, and frequencies and percentages for categorical variables. Normality tests and QQ plots were used to assess the distribution of the data, and appropriate descriptive statistics methods were applied to both normally and non-normally distributed variables. Group comparisons for continuous variables with normal distribution were performed using Welch's t-test or ANOVA, and non-normally distributed variables were compared using the Wilcoxon rank-sum test or Kruskal–Wallis test. For comparison between groups of categorical data, we used the Fisher exact test for expected frequencies < 5; otherwise, we used the Chi-squared test. The Kaplan–Meier method was used to analyze amputation-free survival, freedom from MAEs, overall survival and freedom from MALE, with corresponding survival curves generated. Differences between groups were assessed using the log-rank test. P-value of < 0.05 was considered statistically significant in our study. Results A total of 153 patients with infrapopliteal occlusive CLTI who underwent endovascular revascularization were included in this study. Based on the change in WIfI stage from preoperative to postoperative assessment, patients were divided into two groups: the Non-improved group (n = 75) and the Improved group (n = 78). Baseline characteristics There were no statistically significant differences between the two groups in terms of demographic data and underlying comorbidities (Table 1). The median ages were 71 and 69 years, respectively (P = 0.330), and the body mass index (BMI) values were 23.4 and 24.2 (P = 0.317). Quality of life scores were 1.84 and 2.00, respectively (P = 0.767). No significant differences were observed between the groups regarding sex distribution, smoking history, hypertension, diabetes, hyperlipidemia, or renal insufficiency (all P > 0.05).Table1Patient demographics and baseline characteristicsCharacteristicWIfI stage changesP-value#OverallN = 153*WIfI-Non-ImprovedN = 75WIfI-ImprovedN = 78Baseline characteristicsAge, year69 (62, 78)71 (62, 81)69 (62, 76)0.330BMI23.9 (21.5, 26.0)23.4 (20.8, 26.1)24.2 (22.2, 26.0)0.317VascuQol2.00 (1.28, 2.72)1.84 (1.40, 2.56)2.00 (1.28, 2.84)0.767Gender0.369Male107 (69.93%)55 (73.33%)52 (66.67%)Female46 (30.07%)20 (26.67%)26 (33.33%)Smoking48 (31.37%)25 (33.33%)23 (29.49%)0.608Hyperlipidemia67 (43.79%)34 (45.33%)33 (42.31%)0.706Hypertension102 (66.67%)50 (66.67%)52 (66.67%) > 0.999Diabetes121 (79.08%)60 (80.00%)61 (78.21%)0.785Renal insufficiency18 (11.76%)12 (16.00%)6 (7.69%)0.111History of limb intervention39 (25.49%)15 (20.00%)24 (30.77%)0.127Lesion and perioperative characteristicsRutherford0.007R422 (14.38%)5 (6.67%)17 (21.79%)R5116 (75.82%)59 (78.67%)57 (73.08%)R615 (9.80%)11 (14.67%)4 (5.13%)Preoperative WIfI stage0.005249 (32.03%)22 (29.33%)27 (34.62%)368 (44.44%)27 (36.00%)41 (52.56%)436 (23.53%)26 (34.67%)10 (12.82%)Number of infrapopliteal artery lesions0.092110 (6.54%)8 (10.67%)2 (2.56%)230 (19.61%)12 (16.00%)18 (23.08%)3113 (73.86%)55 (73.33%)58 (74.36%)Infrapopliteal run-off score10.0 (8.5, 14.0)9.5 (8.0, 13.0)10.0 (9.0, 15.0)0.042Inflow tract intervention90 (58.82%)39 (52.00%)51 (65.38%)0.093Ipsilateral aortoiliac intervention6 (3.92%)2 (2.67%)4 (5.13%)0.682Ipsilateral femoropopliteal intervention89 (58.17%)39 (52.00%)50 (64.10%)0.129Ipsilateral inframalleolar intervention24 (15.69%)18 (24.00%)6 (7.69%)0.006Number of infrapopliteal runoff vessels0.604174 (48.37%)35 (46.67%)39 (50.00%)264 (41.83%)34 (45.33%)30 (38.46%)315 (9.80%)6 (8.00%)9 (11.54%)Postoperative Infrapopliteal Run-off Score6.50 (4.00, 7.00)6.50 (4.00, 7.00)6.50 (4.00, 7.00)0.328Postoperative WIfI stage < 0.001152 (33.99%)0 (0.00%)52 (66.67%)238 (24.84%)19 (25.33%)19 (24.36%)336 (23.53%)29 (38.67%)7 (8.97%)427 (17.65%)27 (36.00%)0 (0.00%)Perioperative Complications2 (1.31%)2 (2.67%)0 (0.00%)0.239Total cost, Yuan112,887 (86,280, 142,513)115,119 (86,308, 156,453)111,696 (80,586, 140,743)0.290Length of stay, day7.0 (4.0, 10.0)7.0 (4.0, 10.0)7.0 (4.0, 10.0)0.702*Median (Q1, Q3); n (%)#Wilcoxon rank sum test; Pearson's Chi-squared test; Fisher's exact testVascuQol, Vascular Quality of Life Table1Patient demographics and baseline characteristicsCharacteristicWIfI stage changesP-value#OverallN = 153*WIfI-Non-ImprovedN = 75WIfI-ImprovedN = 78Baseline characteristicsAge, year69 (62, 78)71 (62, 81)69 (62, 76)0.330BMI23.9 (21.5, 26.0)23.4 (20.8, 26.1)24.2 (22.2, 26.0)0.317VascuQol2.00 (1.28, 2.72)1.84 (1.40, 2.56)2.00 (1.28, 2.84)0.767Gender0.369Male107 (69.93%)55 (73.33%)52 (66.67%)Female46 (30.07%)20 (26.67%)26 (33.33%)Smoking48 (31.37%)25 (33.33%)23 (29.49%)0.608Hyperlipidemia67 (43.79%)34 (45.33%)33 (42.31%)0.706Hypertension102 (66.67%)50 (66.67%)52 (66.67%) > 0.999Diabetes121 (79.08%)60 (80.00%)61 (78.21%)0.785Renal insufficiency18 (11.76%)12 (16.00%)6 (7.69%)0.111History of limb intervention39 (25.49%)15 (20.00%)24 (30.77%)0.127Lesion and perioperative characteristicsRutherford0.007R422 (14.38%)5 (6.67%)17 (21.79%)R5116 (75.82%)59 (78.67%)57 (73.08%)R615 (9.80%)11 (14.67%)4 (5.13%)Preoperative WIfI stage0.005249 (32.03%)22 (29.33%)27 (34.62%)368 (44.44%)27 (36.00%)41 (52.56%)436 (23.53%)26 (34.67%)10 (12.82%)Number of infrapopliteal artery lesions0.092110 (6.54%)8 (10.67%)2 (2.56%)230 (19.61%)12 (16.00%)18 (23.08%)3113 (73.86%)55 (73.33%)58 (74.36%)Infrapopliteal run-off score10.0 (8.5, 14.0)9.5 (8.0, 13.0)10.0 (9.0, 15.0)0.042Inflow tract intervention90 (58.82%)39 (52.00%)51 (65.38%)0.093Ipsilateral aortoiliac intervention6 (3.92%)2 (2.67%)4 (5.13%)0.682Ipsilateral femoropopliteal intervention89 (58.17%)39 (52.00%)50 (64.10%)0.129Ipsilateral inframalleolar intervention24 (15.69%)18 (24.00%)6 (7.69%)0.006Number of infrapopliteal runoff vessels0.604174 (48.37%)35 (46.67%)39 (50.00%)264 (41.83%)34 (45.33%)30 (38.46%)315 (9.80%)6 (8.00%)9 (11.54%)Postoperative Infrapopliteal Run-off Score6.50 (4.00, 7.00)6.50 (4.00, 7.00)6.50 (4.00, 7.00)0.328Postoperative WIfI stage < 0.001152 (33.99%)0 (0.00%)52 (66.67%)238 (24.84%)19 (25.33%)19 (24.36%)336 (23.53%)29 (38.67%)7 (8.97%)427 (17.65%)27 (36.00%)0 (0.00%)Perioperative Complications2 (1.31%)2 (2.67%)0 (0.00%)0.239Total cost, Yuan112,887 (86,280, 142,513)115,119 (86,308, 156,453)111,696 (80,586, 140,743)0.290Length of stay, day7.0 (4.0, 10.0)7.0 (4.0, 10.0)7.0 (4.0, 10.0)0.702*Median (Q1, Q3); n (%)#Wilcoxon rank sum test; Pearson's Chi-squared test; Fisher's exact testVascuQol, Vascular Quality of Life Patient demographics and baseline characteristics *Median (Q1, Q3); n (%) #Wilcoxon rank sum test; Pearson's Chi-squared test; Fisher's exact test VascuQol, Vascular Quality of Life Lesion and perioperative characteristics There was a statistically significant difference in the distribution of Rutherford classifications between the two groups (P = 0.007). The WIfI-Improved group had a higher proportion of Rutherford 4 patients (21.79% vs. 6.67%), whereas the WIfI-Non-Improved group had a higher proportion of Rutherford 6 patients (14.67% vs. 5.13%). Preoperative WIfI staging also differed significantly between groups (P = 0.005), with a greater proportion of WIfI stage 4 in the WIfI-Non-Improved group (34.67% vs. 12.82%), indicating more severe initial limb threat. The number of infrapopliteal arterial lesions was similar between groups, with triple-vessel disease being the most common (overall 73.86%). Both groups had comparable intraoperative treatment strategies, with no significant differences in the rates of inflow vessel intervention (including ipsilateral common iliac, femoral, and popliteal arteries). However, WIfI-Non-Improved group underwent significantly more ipsilateral infrapopliteal artery interventions (24.00% vs. 7.69%, P = 0.006), reflecting greater lesion complexity. The overall incidence of perioperative complications was low, with only 2 cases (2.67%), and the difference between groups was not statistically significant (P = 0.239). Primary outcome and secondary outcomes During the 1-year follow-up period, 10/153 (6.54%) suffered from major amputation, 15/153 (9.80%) underwent targeted limb re-intervention due to ischemia, 24/153 (15.69%) developed MALE, 22/153 (14.38%) suffered from major amputation or death, 13/153 (8.50%) died due to all causes, and 36/153 (23.53%) patients experienced MAEs. Kaplan–Meier analysis demonstrated that the WIfI-Improved group had a significantly higher freedom from MAEs within one year postoperatively compared to the WIfI-Non-Improved group (P = 0.011). At the 1-year follow-up, the improved group exhibited a notably higher MAE-free rate, suggesting that WIfI stage improvement is significantly associated with a reduced risk of major adverse events after revascularization (Fig. 1A). The number of patients at risk at each time point was similar between groups throughout the follow-up period, indicating good data reliability.Fig. 1Kaplan–Meier analyses for 12-month outcomes: freedom from MAE (A), amputation-free survival (B), overall survival (C), freedom from MALE (D) Kaplan–Meier analyses for 12-month outcomes: freedom from MAE (A), amputation-free survival (B), overall survival (C), freedom from MALE (D) Comparing AFS between the two groups, Kaplan–Meier analysis showed that the WIfI-Improved group achieved superior AFS outcomes at 1 year postoperatively. The difference was statistically significant (P = 0.011) (Fig. 1B). Regarding overall survival, Kaplan–Meier analysis indicated that the WIfI-Improved group had a significantly higher survival rate at 1 year after surgery compared to the Non-improved group (P = 0.005) (Fig. 1C). For MALE, Kaplan–Meier analysis showed a slightly higher MALE-free rate in the WIfI-Improved group within 1 year postoperatively, but the difference between groups was not statistically significant (P = 0.209) (Fig. 1D). Discussion The WIfI classification system was first proposed by the SVS in 2014. It evaluates the severity of Wound, Ischemia, and Foot Infection to provide a standardized grading system for assessing the limb threat level in patients with CLTI. The original WIfI system generated 64 theoretical wound, infection, and ischemia combinations. The 12-member consensus panel classified these WIfI combinations into four groups of revascularization benefit (very low, low, moderate, and high). Numerous studies have confirmed that the progression of preoperative WIfI clinical staging is associated with an increased risk of major amputation following revascularization. A meta-analysis article in 2019 validated the prognostic value of WIfI grading in CLTI patients. Through screening, a total of 12 relevant studies were identified, of which 11 were retrospective, single center studies. In a retrospective, dual center study, WIfI grading was found to be associated with the prognosis of amputation, survival without amputation, and wound healing are significantly correlated [21]. As WIfI stages advance, the likelihood of major amputation exhibits a stepwise increase, highlighting the potential of this classification system as an integral component in clinical decision-making for all WIfI risk patients [10, 22, 23]. In the latest Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial, it was observed that WIfI staging is closely associated with major amputation, mortality, and MALE (major adverse limb events)/mortality following revascularization in patients with CLTI. Compared to WIfI stages 1 and 2, patients in clinical stages 3 and 4 had significantly higher rates of major amputation (21.4% and 16.2% vs. 10.7%), mortality (33.5% and 35.7% vs. 24.6%), amputation/mortality (44.9% and 44.5% vs. 31.3%), MALE/mortality (34.4and 33.9% vs. 29.5%), and reintervention/amputation/mortality (69.9% and 69.0% vs. 60.4%) [8]. Similarly, data from the Vascular Quality Initiative (VQI) Peripheral Vascular Intervention (PVI) database, which includes long-term follow-up of 28,727 patients with documented wound, ischemia, and infection, demonstrated that the estimated 1-year rates of major amputation or death significantly increased with each WIfI stage: stage 1 (7.7%), stage 2 (8.2%), stage 3 (14.7%), and stage 4 (20.2%) [7]. However, there are still certain limitations to the current WIfI system. For instance, the impact of WIfI stage changes caused by surgical intervention has not been fully considered. With advancements in endovascular techniques, an increasing number of patients are likely to benefit from such procedures. Postoperative changes in WIfI stages are common following successful interventions, raising questions about the reliability of preoperative WIfI assessments in predicting the success of revascularization. Previous studies have attempted to incorporate WIfI scoring into post-intervention reassessments. For example, Leithead et al. [13] demonstrated that changes in WIfI scores after surgery could effectively predict outcomes. However, there remains a lack of comprehensive research on whether dynamic adjustments in WIfI staging, reflecting postoperative changes, can accurately indicate the effectiveness of interventions and predict long-term outcomes. A study by Cheun et al. [14] found that postoperative WIfI stages were significantly associated with 1-year and 5-year AFS and MALE. However, the study had limitations, such as failing to account for the outcomes of endovascular revascularization. Additionally, the study did not provide details on intervention methods or lesion characteristics, leaving gaps in understanding the full impact of WIfI staging adjustments. This study further extends the concept of dynamic WIfI classification changes and, to the best of our knowledge, is the first to explore the impact of post-endovascular WIfI stage changes on 1-year short-term outcomes in CLTI patients with infrapopliteal artery lesions. In this study, patients were divided into two groups based on postoperative WIfI stage dynamics: the "WIfI-improved Group" (with better WIfI staging after surgery) and the "WIfI-Non-Improved Group" (with: no change or any increase in WIfI stage postoperatively). The results showed that, compared to patients with unchanged WIfI stages, those whose WIfI stages improved had significantly lower risks of MAEs within 1 year (P = 0.011), markedly improved AFS (P = 0.011), and a notably reduced risk of death (P = 0.005). These findings suggest that postoperative improvement in WIfI stages not only reflects a localized alleviation of disease but also potentially indicates the effectiveness of overall circulatory reconstruction and substantial improvement in lower limb perfusion. It is worth noting, however, that the predictive capacity of WIfI staging for major adverse limb events (MALEs) was relatively limited in this study, as no statistically significant difference was observed (P = 0.209). Possible reasons for this include the weaker correlation between certain limb-related events, such as reintervention, and WIfI staging. Additionally, key postoperative variables, such as antiplatelet therapy adherence and post-surgery mobility, were not included, which might have influenced the dynamic predictive ability of WIfI staging. The relatively small sample size may also have contributed to the lack of statistical significance. This is evident in the Kaplan–Meier curves, where the two groups show clear stratification, but the limited sample size and low incidence of positive events may have prevented the differences from reaching statistical significance. This study investigated the prognostic value of pre- and postoperative WIfI classification changes on mid- to long-term outcomes in patients with BTK occlusive CLTI undergoing endovascular revascularization. The results demonstrated that postoperative improvement in WIfI classification was closely associated with significant reductions in MAE, improved AFS, and lower mortality rates. These findings suggest that WIfI classification not only holds value in preoperative risk assessment but that its dynamic changes can also serve as a critical reference for postoperative prognosis evaluation. From a clinical perspective, dynamic postoperative WIfI assessment could be utilized as a supportive decision-making tool, providing guidance for follow-up care and determining the timing of reintervention. For instance, patients without postoperative improvement in WIfI stages should be closely monitored for the potential need for revascularization, infection control, and wound management. Conversely, those with improved WIfI stages might be transitioned to conservative management and functional rehabilitation, enabling a more individualized approach to patient care. Furthermore, dynamic WIfI assessment provides a straightforward prognostic tool to facilitate patient counseling, helping patients understand their progress and reinforcing adherence to secondary prevention measures, such as smoking cessation, glycemic control, and antiplatelet therapy. Limitations This study has several limitations. First, it is a single-center study with a limited sample size, which may introduce selection bias. Second, there may be some degree of subjectivity in WIfI scoring among different operators. Although efforts were made to minimize bias through dual reviews and standardized definitions, interobserver variability cannot be completely eliminated. Third, the follow-up period in this study was limited to 1 year, making it impossible to evaluate the long-term dynamics of amputation and survival rates. Furthermore, the imbalance in baseline data of the affected limb may affect the results. Future research should focus on validating the predictive modeling of the WIfI classification system in the postoperative setting through large-scale, multicenter prospective cohorts. Such studies would enhance the clinical applicability and consistency of WIfI scoring, ultimately improving its utility in practice. Conclusion This study demonstrates that postoperative improvement in WIfI classification is closely associated with a lower incidence of MAEs, higher AFS, and reduced mortality risk in patients with infrapopliteal artery occlusive CLTI undergoing endovascular revascularization. These findings suggest that dynamic changes in WIfI classification can serve as an important reference for postoperative prognosis evaluation, contributing to risk stratification and optimization of management strategies for postoperative patients.